Four-year experience with methotrexate exposures.

被引：16

作者：

LoVecchio F. ^{[1
]}

Katz K. ^{[1
]}

Watts D. ^{[1
]}

Wood I. ^{[1
]}

机构：

[1] Banner Good Samaritan Regional Poison Center, Maricopa Medical Center, Department of Emergency Medicine, Phoenix, AZ

来源：

Journal of Medical Toxicology | 2008年 / 4卷 / 3期

关键词：

methotrexate; poisoning; toxicity; oral;

D O I：

10.1007/BF03161192

中图分类号：

学科分类号：

摘要：

INTRODUCTION: Unintentional methotrexate (MTX) acute oral overdose is rarely reported. METHODS: We conducted a retrospective chart review of all human exposure calls (>150,000 charts) for MTX ingestions reported to our Poison Center during 2000-2003. RESULTS: Thirteen patients met the criteria. The average amount of MTX ingested was 13.03 mg (data from 7 cases), and the average patient age was 43 years (20 months to 80 years). No significant toxicities occurred. DISCUSSION: Although intravenous MTX toxicity can be severe, this does not appear to be a phenomenon associated with either acute unintentional or suicidal oral ingestion.

引用

页码：149 / 150

页数：1

共 50 条

[21] Two adolescents with ectopic pregnancies: Experience with methotrexate
Waseem, Muhammad
Gernsheimer, Joel
Perales, Orlando
PEDIATRIC EMERGENCY CARE, 2006, 22 (07) : 497 - 499
[22] Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center
Toce, Michael S.
Burns, Michele M.
O'Donnell, Katherine A.
CLINICAL TOXICOLOGY, 2017, 55 (01) : 12 - 17
[23] Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
Massimiliano Scalvenzi
Angela Patrì
Claudia Costa
Matteo Megna
Maddalena Napolitano
Gabriella Fabbrocini
Nicola Balato
Dermatology and Therapy, 2019, 9 : 369 - 372
[24] Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
Scalvenzi, Massimiliano
Patri, Angela
Costa, Claudia
Megna, Matteo
Napolitano, Maddalena
Fabbrocini, Gabriella
Balato, Nicola
DERMATOLOGY AND THERAPY, 2019, 9 (02) : 369 - 372
[25] METHOTREXATE THERAPY IN RHEUMATOID-ARTHRITIS - A 2 YEAR PROSPECTIVE FOLLOW-UP
DROSOS, AA
PSYCHOS, D
ANDONOPOULOS, AP
STEFANAKINIKOU, S
TSIANOS, EB
MOUTSOPOULOS, HM
CLINICAL RHEUMATOLOGY, 1990, 9 (03) : 333 - 341
[26] Methotrexate for oral mucous membrane (cicatricial) pemphigoid: experience at an academic dermatology outpatient clinic
Hrin, Matthew L.
Williams, Josiah A.
Bowers, Nathan L.
Ahn, Christine S.
Strowd, Lindsay C.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1431 - 1433
[27] Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer Four-year outcomes
Rochet, Nathalie
Lindel, Katja
Katayama, Sonja
Schubert, Kai
Herfarth, Klaus
Schneeweiss, Andreas
Sohn, Christoph
Harms, Wolfgang
Debus, Juergen
STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (07) : 582 - 589
[28] Atypical experience: A case series of pediatric aripiprazole exposures
Lofton, AL
Klein-Schwartz, W
CLINICAL TOXICOLOGY, 2005, 43 (03) : 151 - 153
[29] Comparison of four regimens of misoprostol after methotrexate for early abortion
Wiebe, Ellen
Hernpstock, Wendy
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 101 (02) : 192 - 193
[30] The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
Wu, Xiaodong
Qin, Jiale
Shen, Tao
Fei, Weidong
Chen, Lili
Xie, Xing
Lu, Weiguo
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (04) : 1 - 11

← 1 2 3 4 5 →